Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 2

The Effects of Demographic, Clinical, and Radiological Parameters of Multiple Sclerosis on Quality of Life and Fatigue

Pages
206–212
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Methods: The study included 100 patients who met the 2010 McDonald’s criteria, had an Expanded Disability Status Scale (EDSS) score of

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Multiple sclerosis is a progressive disease involving the central nervous system, usually starting between 20 and 40 years of age and causing recurrent dysfunction.
📊
Key Findings & Data:There may be differences in physical, social and psychological effects depending on the degree of the disease.
💡
Conclusion & Impact:Methods: The study included 100 patients who met the 2010 McDonald’s criteria, had an Expanded Disability Status Scale (EDSS) score of
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Multiple sclerosis is a progressive disease involving the central nervous system, usually starting between 20 and 40 years of age and causing recurrent dysfunction. There may be differences in physical, social and psychological effects depending on the degree of the disease. Fatigue is a common symptom of MS, which can be seen in different disease degrees and affects quality of life. The relationship between clinical and radiological findings and fatigue and quality of life remains unclear. Therefore, the purpose of the research is to evaluate the relationship between disease markers such as age, mood, physical disability, laboratory findings, and fatigue and quality of life. Methods: The study included 100 patients who met the 2010 McDonald’s criteria, had an Expanded Disability Status Scale (EDSS) score of

🔖

Cite This Article

TÜZÜN, E., BULUT, N., TÜRKOĞLU, R., ARSOY, E., DELİPOYRAZ, İ. (2022). The Effects of Demographic, Clinical, and Radiological Parameters of Multiple Sclerosis on Quality of Life and Fatigue. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 2, 206–212. https://ajindex.com/articles/535846

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Benito-león J, Morales JM, Rivera-Navarro J, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil. 2003;25(23):1291–303
  2. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol. 2002;249:1027–33
  3. Skerrett TN, Moss-Morris R. Fatigue and social impairment in multiple sclerosis: The role of patients’ cognitive and behavioral responses to their symptoms. J Psychosom Res. 2006;61:587–93
  4. Walker LAS, Berard JA, Berrigan LI, Rees LM, Freedman MS. Detecting cognitive fatigue in multiple sclerosis: Method matters. J Neurol Sci [Internet]. 2012;316:86–92. Available from:
  5. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H, Kappos L, et al. Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the “McDonald Criteria.” Ann Neurol. 2005;58:840– 6
  6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983;33(November):1444–52
  7. Fischer J, Rudick R, Cutter G, Reingold S. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;(5):244–50
  8. Ozakbas S, Cagiran I, Ormeci B, Idiman E. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci. 2004;218:3–7
  9. Armutlu K, Keser İ, Korkmaz N, Akbiyik Dİ, Sumbuloglu V, Guney Z, et al. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. J Neurol Sci. 2007;255:64–8
  10. Kapci EG, Uslu R, Turkcapar H, Karaoglan A. Beck Depression Inventory II: Evaluation of the Psychometric Proporties and Cut-Off Points in a Turkish Adult Population. Depress Anxiety. 2008;25:104–10
  11. Bilir Kaya B, Icagasioglu A. Reliability and validity of the Turkish version of short form 36 (SF-36) in patients with rheumatoid arthritis. J Surg Med. 2018;2(1):11–6
  12. Ware JE, Gandek B, Group IP. The SF-36 Health Survey: Development and Use in Mental Health Research and the IQOLA Project. Int J Ment Health. 1994;23(2):49–73
  13. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The Impact of Fatigue on Patients with Multiple Sclerosis. Can J Neurol Sci. 1994;21:9